[Skip to Navigation]
June 2016

Do It Yourself Newborn Screening

Author Affiliations
  • 1Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer, Leuven, Belgium
  • 2Centre of Genomics and Policy, Department of Human Genetics, McGill University, Montreal, Quebec, Canada
JAMA Pediatr. 2016;170(6):523-524. doi:10.1001/jamapediatrics.2016.0166

Direct-to-consumer (DTC) genetic testing on the Internet is flourishing and now includes disease risk testing that complements health care. Direct-to-consumer genetic testing continues to raise concerns, notably about consent and counseling issues, in addition to the clinical validity and utility of the tests. Direct-to-consumer genetic testing in children adds specific issues.1 Clinical guidelines currently advocate that testing and screening minors is only recommended when established, effective, and important medical treatment can be offered or when testing provides scope for treatment that may prevent, defer, or alleviate the outbreak of disease or its consequences. This reflects the careful consideration that is usually given to genetic tests, for which special attention is paid to communication about the test and its results, the confidentiality of genetic information, the willingness of the client to make the request, and the psychosocial impact of the test results. Recently, a new form of DTC genetic tests for children has emerged that raises additional ethical issues: a supplemental newborn screening (NBS) test sold to expecting couples. Although a few companies already sell such tests, the Baby Genes service is novel in several respects (https://www.babygenes.net).

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Education and Advancement of Newborn Screening
    Max Truesdel | Baby Genes, Inc.
    A point of clarification from Baby Genes, Inc.<br/><br/>https://www.babygenes.net/2016/04/baby-genes-inc-overview-and-applications/
    CONFLICT OF INTEREST: Baby Genes, Inc. is a privately held company based in Golden, Colorado focused on advancing newborn screening and education.